Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 53, Issue 2, 2013, Pages 130-135

  Wender Ozegowska, Ewa ^a   Zawiejska, Agnieszka ^a   Ozegowska, Katarzyna ^a   Wroblewska Seniuk, Katarzyna ^a   Iciek, Rafal ^a   Mantaj, Urszula ^a   Olejniczak, Danuta ^a   Brazert, Jacek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CSII; diabetic pregnancy; MDI; pregnancy outcome

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FETUS OUTCOME; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; METABOLIC REGULATION; OBSERVATIONAL STUDY; ONSET AGE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876283794     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12027     Document Type: Article

References (30)

1. St. Vincent Declaration. Italy 10-12 October 1989; www. diabetesguidelines.com/health/dwk/pro/guidelines/ispad/20-04.asp.
2. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2011; 34 (Suppl 1): 11-61.
3. De Hertogh R,. Maternal diabetes and embryonic development. In:, Djelmiš J, Desoye G, Ivaniševic′ M,. eds. Diabetology of Pregnancy. Front Diabetes, vol 17. Basel: Karger, 2005; 58-61.
4. Eriksson UJ, Wentzel P, Hod M,. Clinical and experimental advances in the understanding of diabetic embryopathy. In:, Hod M, Jovanovic L, Di Renzo JC, de Leiva A, Langer O, eds. Textbook of Diabetes and Pregnancy. London: Martin Dunitz, 2003, 262-275.
5. Handisurya A, Bancher-Todesca D, Schober E, et al,. Risk factor profile and pregnancy outcome in women with type 1 and type 2 diabetes mellitus. J Womens Health 2011; 20: 263-271.
6. Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA,. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2010; 14: 10-63.
7. Temple R,. Preconception care for women with diabetes: is it effective and who should provide it? Best Pract Res Clin Obstet Gynecol 2011; 25: 3-14.
8. Cyganek K, Hebda-Szydlo A, Katra B, et al,. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther 2010; 12: 41-47.
9. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N,. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004; 8 (43): 1-171.
10. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM,. Hypoglycemia with intensive insulin therapy: a systematic review and metaanalyses of randomized trials of continuous subcutaneous insulin infusion vs. multiple daily injections. J Clin Endocrinol Metab 2009; 94: 729-740.
11. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT,. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up. Pediatrics 2004; 114: 1601-1605.
12. Wender- Ozegowska E, Bomba-Opoń B, Bra̧zert J, et al,. Polish Gynecological Society standards of medical care in management of women with diabetes. Ginek Pol 2011; 82: 474-479.
13. Czech A, Cypryk K, Czupryniak L, et al,. Clinical recommendations on treatment of diabetes-Polish Diabetes Society [Zalecenia kliniczne dotycza̧ce postȩpowania u chorych na cukrzycȩ 2011. Stanowisko Polskiego Towarzystwa Diabetologicznego]. Diabet Dośw Klin. 2011; T. 11 (suppl A s): A1-A48.
14. Gadzinowski J, Kaliszewska-Drozdowska MD, Kosińska M, Mazela J, Stoińska B,. Birth weight and gestational age in newborns born in Wielkopolska and Ziemia Lubuska regions [Urodzeniowa masa ciała a wiek płodowy noworodkõw regionu Wielkopolski i Ziemi Lubuskiej]. Ginek Pol 2003; 74: 186-192.
15. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
16. Chen R, Ben-Harousch A, Weissmann-Brenner A, Melamed N, Hod M, Yogev Y,. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007; 1997: 404. e1-404e5.
17. Kordonouri O, Hartmann R, Lauterborn R, Barnekow C, Hoeffe J, Deiss D,. Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in paediatric patients: one-year follow-up comparison by matched-pair analysis. Diabetes Care 2006; 29: 133-134.
18. Burkart W, Hanker JP, Schneider HP,. Complications and fetal outcome in diabetic pregnancy. Intensified conventional versus insulin pump therapy. Gynecol Obstet Invest 1988; 26: 104-112.
19. Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM,. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 1986; 255: 631-636.
20. Gabbe SG, Holing E, Temple P, Brown ZA,. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000; 182: 1283-1291.
21. Hieronimus S, Cupelli C, Bongain A, Durand-Reville M, Berthier F, Fenichel P,. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005; 33: 389-394.
22. Cypryk K, Kosiński M, Kamińska P, Kozdraj T, Lewiński A,. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. Pol Arch Med Wewn 2008; 118: 339-344.
23. Lapolla A, Dalfra MG, Masin M, Bruttomesso D, Piva I, Crepaldi C,. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003; 40: 143-149.
24. Nathan DM, Zinman B, Cleary PA, et al,. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Arch Intern Med 2009; 169: 1307-1316.
25. DCCT Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18: 1415-1427.
26. Jovanovic L,. Medical Management of Pregnancy Complicated by Diabetes. Alexandria: American Diabetes Association, 2000.
27. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH,. Macrosomia despite good glycemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002; 45: 1484-1489.
28. Kernaghan D, Farrell T, Hammond P, Owen P,. Fetal growth in women managed with insulin pump therapy compared to conventional insulin. Eur J Obstet Gynecol Reprod Biol 2008; 137: 47-49.
29. Pearson DW, Kernaghan D, Lee R, Penney GC,. The relationship between pre- pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG 2007; 114: 104-107.
30. Mukhopadhyay A, Farrel T, Fraser RB, Ola B,. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007; 197: 447-456.